- Diebold Nixdorf Inc DBD reported a third-quarter sales decline of 15.4% year-on-year to $810.4 million, missing the consensus of $843.46 million.
- Adjusted net sales fell 16% to $805.3 million. Adjusted gross profit for the quarter decreased 24.2% to $199.3 million with a profit margin of 24.7%.
- Adjusted operating margin was 7.5%, and the adjusted operating income for the quarter fell 26.2% to $60 million.
- The company held $143 million in cash and equivalents as of September 30, 2022.
- Adjusted EBITDA fell 26.4% to $75.6 million.
- Adjusted EPS loss of $(0.12) missed the analyst consensus of $0.24.
- Price Action: DBD shares are trading higher by 8.29% at $2.28 on the last check Tuesday.
- Photo Via Company
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
